MedTrace Logo

Online Treatment of Trichotillomania

NCT02044237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2016-05-10

No results posted yet for this study

Summary

Online study for patients with trichotillomania. 4 main hypothesis.

1. Alexithymia and Trichotillomania correlated and regression analyses find association between them
2. we will be able to find patient who have never been treated before. Those will suffer to the same amount as previously treated patients
3. Decoupling will be more helpful than progressive muscle relaxation
4. different constructs of emotion regulation will show different trait and state characteristics in patients with trichotillomania

Conditions

  • Trichotillomania
  • Alexithymia
  • Quality of Life

Interventions

BEHAVIORAL

Decoupling

BEHAVIORAL

Progressive relaxation

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Julia Bangerter-Rhyner Foundation Bale switzerland

    collaborator UNKNOWN

  • University of Zurich

    lead OTHER

Principal Investigators

  • Michael Rufer, MD, Prof · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-07-31
Completion
2014-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044237 on ClinicalTrials.gov